 Home > Active Ingredient News > Study of Nervous System > December neurology guidelines and consensus, one article included in the guideline consensus

December neurology guidelines and consensus, one article included in the guideline consensus

 Last Update: 2023-02-03
 Source: Internet
 Author: User

Tags

jackson research login

mechanism drug resistance

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

This article summarizes the guidelines and consensus related to neurological diseases at home and abroad released in December 2022 for you to review and download
.

0Jan2022 ASPN evidence-based clinical guidelines: interventional treatment of low back pain

Painful lumbar spine disease is the main cause of disability, and interventional treatment of lumbar disease is an effective way
to treat pain and disability caused by low back pain.
This article mainly provides evidence-based guidance
for the interventional treatment of low back pain.

Download link:

https://guide.
medlive.
cn/guideline/27498

02Expert
consensus on the construction of biological samples and databases for neurodegenerative diseases In the context of population aging, neurodegenerative diseases are on the rise year by year, and the construction of biological samples and databases for neurodegenerative diseases is very important
for disease research and translation 。 Since there is currently no unified consensus in this field in China, the Clinical Data and Sample Resource Bank Professional Committee of the Chinese Research Hospital Association, together with experts in the field of neurology and biobank in some tertiary hospitals in China, formulated this expert consensus, aiming to promote the construction of high-quality biological samples and databases for neurodegenerative diseases, and promote the development of
neurology research and translational medicine in China.

Download link:

http://guide.
medlive.
cn/guideline/27470

03Consensus
on the diagnosis, treatment and management of cognitive impairment after novel coronavirus pneumonia The spread and spread of coronavirus disease 2019 (COVID-19) (referred to as "new coronary pneumonia") around the world has had a huge impact on the physical and mental health of the people, especially the elderly, about 80% Patients infected with COVID have one or more long-term symptoms (level I evidence).

The World Health Organization (WHO) defines this long-term symptom lasting at least 2 months or more as long-term COVID
.
In addition to pulmonary symptoms, long-term new coronary pneumonia often has a variety of cognitive impairment symptoms such as inattention, disorientation or unresponsiveness (level I evidence).

According to the relevant literature on new coronary pneumonia at home and abroad, combined with the actual situation in China, an expert consensus was formed on the long-term course of new coronary pneumonia and cognitive impairment, related risk factors and management measures, in order to improve the understanding of this disease, reduce the damage of cognitive impairment to human daily functions after new crown pneumonia, and provide reference
for the diagnosis and treatment of patients with cognitive impairment during the prevention and control of new crown pneumonia.

Download link:

http://guide.
medlive.
cn/guideline/27526

Related Reading:

How to diagnose and treat cognitive impairment after the new crown? Take a look at the latest expert consensus

042022 UK Best Practice Guide: Genetic Testing
for Mitochondrial Diseases Primary mitochondrial diseases are a group of neurometabolic disorders characterized by impaired oxidative phosphorylation and are challenging
to diagnose.
This article mainly provides practical guidance
for genetic testing of mitochondrial diseases.

Download link:

http://guide.
medlive.
cn/guideline/27518

052022 AASM Clinical Practice Guidelines: Management of REM Sleep Behavior Disorder In December 2022, the American Academy of Sleep Medicine (AASM) issued guidelines
for the management of REM sleep behavior disorder.
This article provides clinical practice recommendations
for the management of rapid eye movement disorder in adults.

Download link:

http://guide.
medlive.
cn/guideline/27523

062022 HSFC Canadian Stroke Best Practice Recommendations (7th Edition): Management of Acute Stroke (Updated) Over
the past few decades, stroke prevention, treatment and rehabilitation have undergone a radical transformation
.
This is the seventh update of Canada's Best Practice Recommendations for Stroke and provides guidance on the management of acute stroke
.

Download link:

http://guide.
medlive.
cn/guideline/27541

072022 French expert consensus: the role
of immunoreconstitution therapy in the treatment of recurrent multiple sclerosis Recurrent multiple sclerosis (RMS) requires individualized treatment to maximize clinical effect
.
This article provides expert advice
on the use of immunoreconstitution therapy (IRT) in the management of RMS.

Download link:

http://guide.
medlive.
cn/guideline/27617

Guidelines for the diagnosis and treatment of migraine in China (2022 edition)

Migraine is the second most common neurological disability, but there are still problems such as
low diagnostic accuracy and irregular treatment in China.
In recent years, with the in-depth study of the mechanism of migraine, its classification, diagnosis and treatment methods have been updated
.
This guide is organized and formulated by the Neurologist Branch of the Chinese Medical Doctor Association and the Headache and Sensory Disorders Professional Committee of the Chinese Research Hospital Association, and on the basis of the first and second editions of the "Guidelines for the Diagnosis and Treatment of Migraine in China" in 2011 and 2016, through updating and evaluating the high-quality literature on migraine and integrating the opinions of domestic experts in related fields, the definition, epidemiology, pathogenesis, clinical manifestations, classification and diagnosis, differential diagnosis and treatment of migraine are elaborated in detail.
In order to further improve the efficiency of disease diagnosis and treatment and the quality of
clinical management.

Download link:

http://guide.
medlive.
cn/guideline/27612